Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease.
about
Dietary intake and arsenic methylation in a U.S. populationArsenic exposure accelerates atherogenesis in apolipoprotein E-/-miceAssociation of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan.Cancer risks from arsenic in drinking waterReduction in urinary arsenic with bottled-water interventionArsenic-induced skin lesions among Atacameño people in Northern Chile despite good nutrition and centuries of exposurePrevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in TaiwanArsenic-induced dysfunction in relaxation of blood vesselsNutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, IndiaGene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects.Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking waterAssessing the measurement precision of various arsenic forms and arsenic exposure in the National Human Exposure Assessment Survey (NHEXAS).Association between chronic arsenic exposure and nutritional status among the women of child bearing age: a case-control study in BangladeshSusceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE studyMutual interaction between nutritional status and chronic arsenic toxicity due to groundwater contamination in an area of Terai, lowland NepalEnvironmental arsenic exposure, selenium and sputum alpha-1 antitrypsinDietary intake of methionine, cysteine, and protein and urinary arsenic excretion in BangladeshIncreased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhoodLung cancer in a U.S. population with low to moderate arsenic exposureArsenic biotransformation as a cancer promoting factor by inducing DNA damage and disruption of repair mechanismsPeripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart StudyA prospective cohort study of stroke mortality and arsenic in drinking water in Bangladeshi adultsInorganic arsenic: a need and an opportunity to improve risk assessmentProbabilistic Modeling of Dietary Arsenic Exposure and Dose and Evaluation with 2003-2004 NHANES DataArsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem.Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenicDrinking water arsenic in Utah: A cohort mortality study.Cardiovascular disease and arsenic exposure in Inner Mongolia, China: a case control studyHistone deacetylase 6 associates with ribosomes and regulates de novo protein translation during arsenite stressCancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water.Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status.The Genetic Architecture of Arsenic Metabolism Efficiency:A SNP-Based Heritability Study of Bangladeshi Adults.Arsenic exposure and cardiovascular disease: an updated systematic reviewMutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of TaiwanAssociations between arsenic in drinking water and pterygium in southwestern Taiwan.Risk Assessment of Arsenic in Rice Cereal and Other Dietary Sources for Infants and Toddlers in the U.S.A high-selenium lentil dietary intervention in Bangladesh to counteract arsenic toxicity: study protocol for a randomized controlled trial.Human arsenic poisoning issues in central-east Indian locations: biomarkers and biochemical monitoring.In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic.
P2860
Q23911286-B44689D3-382A-4EE4-BEB1-98BEEA11CB03Q23919503-E368FB53-FF60-4EC8-A87E-6FD395CDF87AQ24530205-449A1E09-F71F-4DA6-B5BF-B22659EF1237Q24554413-38D2E13F-9065-4D58-9EAD-F1693ADBA06FQ24631091-38605DBA-84C0-43C6-85AD-780662B8CFCCQ24670515-0131DA9A-D7E7-40F1-AD8B-ED74303E49BBQ24813433-505A6A77-7A2A-4302-AD42-A31960C20C16Q24814266-13AF0CB4-CE2E-4F1A-B995-84ACCCA11749Q24815161-DC08A80B-274B-4414-B40E-2D33D648E2C3Q24815894-AB565970-01F8-471D-8A4A-22E373411327Q24817103-25C3452F-5C8A-442B-8247-1E0F2FEE9512Q25257360-20596316-A51E-4F91-8A13-67F1FD5A1F82Q28382845-9FA2E3D1-71E8-4A19-8207-9E77B45DB7A5Q28382944-546BD90B-4BB4-4F6A-AF6A-67474C375969Q28384884-38D81FE5-5E82-4348-B39E-8E8CF31D06E9Q28385707-DA2ED49E-93A9-4362-9369-3DAFB1C7EA31Q28387126-83EAC7FA-0C37-48E5-8196-D83837763E1BQ28390288-460AEE00-E388-4A61-9531-A76E7FAB056AQ28392929-E33DC4E7-F8BE-4090-8562-0C8EA40F092BQ28392983-7E9277D1-1F18-4D5A-AAE9-D3066DCED91BQ28396309-4F2BD2A0-701D-44B1-8D1D-2D89BB2AA8BBQ28396900-40017E0C-C38B-458A-8EBD-625CC89F9BA0Q28768710-9EAF5077-FF03-4E43-BBE4-A29386294C49Q33535609-87BE83B8-F5D9-4CB0-9FA0-65FCFE6D0E51Q33870323-D5724FCD-6ABE-4762-8DDA-03EF0A781526Q34330882-05927DE2-EDA2-498F-8285-9E0A1E48837AQ34691948-C06927D2-25E8-42B3-86AE-4C042D7542EBQ35029875-491A8AE4-EF81-4F11-9AB0-E818B8F6842BQ35538844-3820CAE8-EE0C-49B9-B4D7-AC1B8BBF03B0Q35892799-EBBE42F3-F361-451F-A1BB-AC8E7EF7C9EAQ35994544-FAEB647B-1C1B-4A35-AA46-24BBC2025072Q36079946-6818243F-CA6B-4AA7-B7A5-B0350A76C136Q36112066-93CCA907-CC42-4291-B06D-54CEE78D7313Q36354209-F1F2BF8F-EFC0-4C31-90B0-4279C638EC2FQ36620304-227C024A-1B66-4F03-A7C9-E50A4718B5DAQ36755586-2A5E6E15-758A-4C1F-A9FB-07A3FB896472Q36841580-6D74EF80-32FC-468D-8D49-E1039B4BB6A1Q36846697-F8ED329C-6AAF-4B07-9D72-C4B14400E63DQ37037186-08C76EBB-6B25-4586-94A1-9F2C2D982C69Q42583516-CF684986-AA5B-4CB2-B8C4-B1AC6DC5236A
P2860
Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Atherogenicity and carcinogeni ...... eoplasms of blackfoot disease.
@en
Atherogenicity and carcinogeni ...... eoplasms of blackfoot disease.
@nl
type
label
Atherogenicity and carcinogeni ...... eoplasms of blackfoot disease.
@en
Atherogenicity and carcinogeni ...... eoplasms of blackfoot disease.
@nl
prefLabel
Atherogenicity and carcinogeni ...... eoplasms of blackfoot disease.
@en
Atherogenicity and carcinogeni ...... eoplasms of blackfoot disease.
@nl
P2093
P1476
Atherogenicity and carcinogeni ...... eoplasms of blackfoot disease.
@en
P2093
P304
P577
1988-09-01T00:00:00Z